Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs.
Sedona SweeneyZoe WardLucy PlattLorna GuinnessMatthew HickmanVivian D HopeLisa MaherJenny IversenSharon J HutchinsonJosie SmithRachel AyresIngrid HaineyPeter VickermanPublished in: Addiction (Abingdon, England) (2019)
Needle and syringe programmes are a highly effective low-cost intervention to reduce hepatitis C virus transmission, and in some settings they are cost-saving. Needle and syringe programmes are likely to remain cost-effective irrespective of changes in hepatitis C virus treatment cost and scale-up.